Cargando…

Inhibition of Phosphodiesterase 3A by Cilostazol Dampens Proinflammatory Platelet Functions

Objective: platelets possess not only haemostatic but also inflammatory properties, which combined are thought to play a detrimental role in thromboinflammatory diseases such as acute coronary syndromes and stroke. Phosphodiesterase (PDE) 3 and -5 inhibitors have demonstrated efficacy in secondary p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coenen, Daniëlle M., Heinzmann, Alexandra C. A., Oggero, Silvia, Albers, Hugo J., Nagy, Magdolna, Hagué, Perrine, Kuijpers, Marijke J. E., Vanderwinden, Jean-Marie, van der Meer, Andries D., Perretti, Mauro, Koenen, Rory R., Cosemans, Judith M. E. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392606/ https://www.ncbi.nlm.nih.gov/pubmed/34440764 http://dx.doi.org/10.3390/cells10081998

Ejemplares similares

Combined Antiplatelet Therapy Reduces the Proinflammatory Properties of Activated Platelets
por: Heinzmann, Alexandra C.A., et al.
Publicado: (2021)

Potentiation of imatinib by cilostazol in sensitive and resistant gastrointestinal stromal tumor cell lines involves YAP inhibition
por: Vandenberghe, Pierre, et al.
Publicado: (2019)

Phosphodiesterase 3A: a new player in development of interstitial cells of Cajal and a prospective target in gastrointestinal stromal tumors (GIST)
por: Vandenberghe, Pierre, et al.
Publicado: (2017)

Evaluation of Antidepressant and Anxiolytic Activity of Phosphodiesterase 3 Inhibitor - Cilostazol
por: Patel, Dipesh S., et al.
Publicado: (2012)

The Role of Cilostazol, a Phosphodiesterase 3 Inhibitor, on Oocyte Maturation and Subsequent Pregnancy in Mice
por: Li, Min, et al.
Publicado: (2012)

Phosphodiesterase-3 inhibitor (cilostazol) attenuates oxidative stress-induced mitochondrial dysfunction in the heart
por: Chattipakorn, Siriporn C., et al.
Publicado: (2014)

Anti-photoaging properties of the phosphodiesterase 3 inhibitor cilostazol in ultraviolet B-irradiated hairless mice
por: Kim, Ha Neui, et al.
Publicado: (2016)

EHMTI-0033. The phosphodiesterase 3 inhibitor cilostazol induces migraine-like attacks via cAMP increase
por: Song, G, et al.
Publicado: (2014)

Could cilostazol be beneficial in COVID-19 treatment? Thinking about phosphodiesterase-3 as a therapeutic target
por: Motta, Nadia Alice Vieira, et al.
Publicado: (2021)

Hyperplasia of Interstitial Cells of Cajal in Sprouty Homolog 4 Deficient Mice
por: Thys, An, et al.
Publicado: (2015)

Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

Correction to: Phosphodiesterase (PDE) III inhibitor, Cilostazol, improved memory impairment in aluminum chloride-treated rats: modulation of cAMP/CREB pathway
por: Khalifa, Mona, et al.
Publicado: (2022)

Antagonistic Roles of Human Platelet Integrin αIIbβ3 and Chemokines in Regulating Neutrophil Activation and Fate on Arterial Thrombi Under Flow
por: Schönichen, Claudia, et al.
Publicado: (2023)

Double‐blind, randomized, placebo‐controlled pilot study of the phosphodiesterase‐3 inhibitor cilostazol as an adjunctive to antidepressants in patients with major depressive disorder
por: Abdallah, Mahmoud S., et al.
Publicado: (2021)

Cilostazol, a Phosphodiesterase 3 Inhibitor, Moderately Attenuates Behaviors Depending on Sex in the Ts65Dn Mouse Model of Down Syndrome
por: Tsuji, Masahiro, et al.
Publicado: (2020)

Ferroptosis Induction and YAP Inhibition as New Therapeutic Targets in Gastrointestinal Stromal Tumors (GISTs)
por: Delvaux, Marine, et al.
Publicado: (2022)

Reversal of spatial memory impairment by phosphodiesterase 3 inhibitor cilostazol is associated with reduced neuroinflammation and increased cerebral glucose uptake in aged male mice
por: Yanai, Shuichi, et al.
Publicado: (2022)

Efficacy of cilostazol in canine bradyarrhythmia
por: Ohmori, Takahiro, et al.
Publicado: (2022)

Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
por: Stokol, Tracy, et al.
Publicado: (2016)

To dampen demyelination
por: Maxmen, Amy
Publicado: (2010)

The phosphodiesterase 5 inhibitor sildenafil decreases the proinflammatory chemokine IL-8 in diabetic cardiomyopathy: in vivo and in vitro evidence
por: Giannattasio, S., et al.
Publicado: (2018)

Lactate causes downregulation of Helicobacter pylori adhesin genes sabA and labA while dampening the production of proinflammatory cytokines
por: Somiah, Tanvi, et al.
Publicado: (2022)

Corrigendum: Unfractionated and Low-Molecular-Weight Heparin and the Phosphodiesterase Inhibitors, IBMX and Cilostazol, Block Ex Vivo Equid Herpesvirus Type-1-Induced Platelet Activation
por: Stokol, Tracy, et al.
Publicado: (2017)

Determination of cilostazol and its active metabolite 3,4-dehydro cilostazol from small plasma volume by UPLC−MS/MS
por: Bhatt, Nejal M., et al.
Publicado: (2015)

Pharmacological Potential of Cilostazol for Alzheimer’s Disease
por: Ono, Kenjiro, et al.
Publicado: (2019)

Galectin-1 and platelet factor 4 (CXCL4) induce complementary platelet responses in vitro
por: Dickhout, Annemiek, et al.
Publicado: (2021)

Phosphodiesterase Type 5 Inhibitor Sildenafil Decreases the Proinflammatory Chemokine CXCL10 in Human Cardiomyocytes and in Subjects with Diabetic Cardiomyopathy
por: Di Luigi, Luigi, et al.
Publicado: (2016)

Management of peripheral arterial disease in the elderly: focus on cilostazol
por: Falconer, Travis M, et al.
Publicado: (2008)

DAMPening Inflammation by Modulating TLR Signalling
por: Piccinini, A. M., et al.
Publicado: (2010)

Safety and efficacy of cilostazol in the management of intermittent claudication
por: Chi, Yung-Wei, et al.
Publicado: (2008)

Cilostazol for the prevention of pneumonia: a systematic review
por: Nakashima, Hirotaka, et al.
Publicado: (2018)

Effects of cilostazol on the heart rate in healthy dogs
por: FUKUSHIMA, Ryuji, et al.
Publicado: (2018)

Effect of Cilostazol on the Pharmacokinetics of Simvastatin in Healthy Subjects
por: Kim, Jung-Ryul, et al.
Publicado: (2019)

Population pharmacodynamics of cilostazol in healthy Korean subjects
por: Jung, Yun Seob, et al.
Publicado: (2018)

Cilostazol Prevents Endothelin-Induced Smooth Muscle Constriction and Proliferation
por: Kawanabe, Yoshifumi, et al.
Publicado: (2012)

Splenic schooling dampens inflammation
por: Van Epps, Heather L.
Publicado: (2006)

Sweet inhibitor DAMPens sepsis
por: Paulson, James C., et al.
Publicado: (2011)

Hemorrhagic Cholecystitis in an Elderly Patient Taking Aspirin and Cilostazol
por: Morris, David S., et al.
Publicado: (2008)

Effect of Cilostazol on the Neuropathies of Streptozotocin-Induced Diabetic Rats
por: Suh, Kwang Sik, et al.
Publicado: (1999)

Allium sativum Compared to Cilostazol as an Inhibitor of Myointimal Hyperplasia
por: Lima, Paulo Roberto da Silva, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_jogeodif34rdkm1k5r2e60q4ka